IL-27 Modulates the Cytokine Secretion in the T Cell–Osteoclast Crosstalk During HIV Infection

Tong Li, Colleen Hadigan, Jarred M. Whitlock, Jing Qin, Jai Kumar, Princy Kumar, Marta CatálfamoFrontiers in Immunology 2022 · DOI

Abstract

In People with HIV (PWH), chronic immune activation and systemic inflammation are associated with increased risk to develop comorbidities including bone loss. Numerous cells of the immune system, namely, T cells are involved in the regulation of the bone homeostasis and osteoclasts (OCs) activity. IL-27, a cytokine that belongs to the IL-12 family can regulate the secretion of pro- and anti-inflammatory cytokines by T cells, however its role in the setting of HIV is largely unknown. In the present study, we determined the impact of OCs in T cell secretion of cytokines and whether IL-27 can regulate this function. We found that the presence of OCs in the T cell cultures significantly enhanced secretion of IFNγ, TNFα, IL-17, RANKL, and IL-10 in both PWH and healthy controls. In PWH, IL-27 inhibited IL-17 secretion and downregulated surface expression of RANKL in CD4 T cells. All together these results suggest that in the context of HIV infection IL-27 may favor IFNγ and TNFα secretion at the sites of bone remodeling.

Introduction

People living with HIV (PWH) face a significantly higher risk of low bone mineral density and osteoporosis compared to the general population. This clinical challenge is driven by chronic immune activation and persistent systemic inflammation. Central to bone homeostasis is the biological "conversation" between T cells (immune regulators) and osteoclasts (OCs, the cells that break down bone). T cells produce cytokines that can either stimulate or inhibit bone resorption, but the role of regulatory cytokines like IL-27 in this specific interaction during HIV infection has previously been unclear.

IL-27, a member of the IL-12 family, is known for its complex pro- and anti-inflammatory properties. This study sought to determine if IL-27 could modulate the inflammatory signals that drive bone loss in PWH by regulating the T cell–OC crosstalk.

Materials and Methods

The researchers developed an in vitro autologous coculture system to mimic the bone microenvironment. Monocytes were isolated from PWH (n=26) and healthy controls (HC, n=19) and differentiated into mature osteoclasts. Autologous T cells were then cultured either alone or with these OCs at a 5:1 ratio. The cultures were stimulated via the T-cell receptor (TCR) using CD3/CD28 beads, with or without the addition of recombinant IL-27. Secreted cytokines (IFNγ, TNFα, IL-17, RANKL, and IL-10) were measured using multiplex assays, and flow cytometry was used to analyze surface expression of RANKL and intracellular cytokine production.

Results

Osteoclasts as Potent Costimulators

A striking finding was that OCs act as potent costimulatory cells rather than passive bone-resorbers. Their presence significantly boosted the secretion of all measured cytokines—IFNγ, TNFα, IL-17, RANKL, and IL-10—from T cells in both PWH and healthy controls. For instance, IFNγ secretion increased by roughly 10-fold in cocultures compared to T cells cultured alone.

Cytokine profiles in T cell-osteoclast cocultures and the regulatory effect of IL-27. Panels A-D show the significant boost in cytokine secretion (IFNγ, TNFα, IL-17A, IL-10) when T cells are cocultured with OCs. Panels E-H demonstrate that IL-27 selectively inhibits IL-17A (G) in PWH cocultures.

IL-27 as a Selective Molecular "Brake"

IL-27 provided targeted regulation rather than broad immunosuppression. In PWH, IL-27 specifically inhibited the secretion of IL-17 and the surface expression of RANKL on CD4 T cells, both of which are major drivers of bone resorption. Interestingly, IL-27 did not inhibit the production of IFNγ or TNFα, suggesting a shift toward a Th1-type response while specifically dampening pro-osteoclastic Th17 signals.

Clinical Correlations

The study found a significant inverse correlation (R = -0.67, p = 0.011) between the ability of T cells to secrete IFNγ and the patient's T-score (bone density). Additionally, higher levels of D-dimer, a marker of systemic inflammation, were associated with higher IFNγ production in the T cell:OC cocultures, linking systemic immune status to local bone-cell crosstalk.

Discussion and Conclusion

These results suggest that in the context of HIV infection, IL-27 acts as a selective regulator that may favor Th1-type cytokine secretion while suppressing the bone-damaging IL-17/RANKL axis. While the study was limited by its in vitro nature and the relatively healthy BMD of the cohort, it highlights a potential pathway to mitigate HIV-associated bone loss. Future work should confirm if this cytokine modulation directly translates to reduced bone resorption in functional assays. Understanding these regulatory mechanisms is vital for addressing the long-term inflammatory comorbidities faced by people living with HIV.

Summary updated

Abstract

In People with HIV (PWH), chronic immune activation and systemic inflammation are associated with increased risk to develop comorbidities including bone loss. Numerous cells of the immune system, namely, T cells are involved in the regulation of the bone homeostasis and osteoclasts (OCs) activity. IL-27, a cytokine that belongs to the IL-12 family can regulate the secretion of pro- and anti-inflammatory cytokines by T cells, however its role in the setting of HIV is largely unknown. In the present study, we determined the impact of OCs in T cell secretion of cytokines and whether IL-27 can regulate this function. We found that the presence of OCs in the T cell cultures significantly enhanced secretion of IFNγ, TNFα, IL-17, RANKL, and IL-10 in both PWH and healthy controls. In PWH, IL-27 inhibited IL-17 secretion and downregulated surface expression of RANKL in CD4 T cells. All together these results suggest that in the context of HIV infection IL-27 may favor IFNγ and TNFα secretion at the sites of bone remodeling.
BibTeX
@inproceedings{li2022il,
  author = {Tong Li and Colleen Hadigan and Jarred M. Whitlock and Jing Qin and Jai Kumar and Princy Kumar and Marta Catálfamo},
  title = {{IL-27 Modulates the Cytokine Secretion in the T Cell–Osteoclast Crosstalk During HIV Infection}},
  booktitle = {Frontiers in Immunology},
  year = {2022},
  doi = {10.3389/fimmu.2022.818677},
}
Figure